Palettes of vaccines and immunostimulatory monoclonal antibodies for combination

Ignacio Melero, Ivan Martinez-Forero, Juan Dubrot, Natalia Suarez, Asis Palazón, Lieping Chen

Research output: Contribution to journalArticlepeer-review


Various monoclonal antibodies (mAb) target immune system molecules to enhance immunity by costimulating T cells (i.e., CD137, OX40, CD40, GITR) or interfering in coinhibitory signals (i.e., CTLA-4, PD-1). These powerful agents can be guided by cancer vaccines to enhance immunity against tumor but not self tissues. Clinically powerful therapeutic synergies are at hand.

Original languageEnglish (US)
Pages (from-to)1507-1509
Number of pages3
JournalClinical Cancer Research
Issue number5
StatePublished - Mar 1 2009

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Palettes of vaccines and immunostimulatory monoclonal antibodies for combination'. Together they form a unique fingerprint.

Cite this